Better Therapeutics, Inc.

BTTX · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$40-$40-$6-$6
Dep. & Amort.$3$2$0$0
Deferred Tax$0-$0$0$0
Stock-Based Comp.$2$1$0$0
Change in WC$6-$2$0-$1
Other Non-Cash$0$10-$0-$0
Operating Cash Flow-$29-$31-$6-$6
Investing Activities
PP&E Inv.-$0-$1-$2-$3
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1$0$0$0
Investing Cash Flow-$1-$1-$2-$3
Financing Activities
Debt Repay.$5$29$4$5
Stock Issued$0-$15$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$59$4$4
Financing Cash Flow$5$72$7$9
Forex Effect$0$0$0$0
Net Chg. in Cash-$25$40-$1-$0
Supplemental Information
Beg. Cash$41$0$1$1
End Cash$16$41$0$1
Free Cash Flow-$30-$32-$8-$9
Better Therapeutics, Inc. (BTTX) Financial Statements & Key Stats | AlphaPilot